JCR Pharmaceuticals Co., Ltd. (4552.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 69.26B |
| Enterprise Value | 109.15B |
| P/E Ratio | 25.52 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 1.38 |
| Price/Book Ratio | 1.19 |
| Enterprise/Revenue | 2.37 |
| Enterprise/EBITDA | 15.46 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.01 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 40.32B |
| Revenue/Share | 330.49 |
| Gross Profit | 30.06B |
| EBITDA | 6.18B |
| Net Income | 2.18B |
| Diluted EPS | 17.85 |
Balance Sheet
| Total Cash | 14.01B |
| Total Cash/Share | 114.81 |
| Total Debt | 53.89B |
| Total Debt/Equity | 1.15 |
| Current Ratio | 1.16 |
| Book Value Per Share | 388.21 |
Price History
| 52-Week Change | -12.81 |
| 52-Week High | 824 |
| 52-Week Low | 445 |
| Moving Average 50 Days | 517.12 |
| Moving Average 200 Days | 619.69 |
Statistics
| Average Volume | 658,791 |
| Shares Outstanding | 121.99M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 20 |
| Trailing Annual Dividend Yield | 4.39 |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
| Last Split Date | September 29, 2020 |
AD
